메뉴 건너뛰기




Volumn 48, Issue 11, 1999, Pages 1-4

Update on the treatment of Wegener's granulomatosis

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; GLUCOCORTICOID; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

EID: 0033492982     PISSN: 00075248     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (8)

References (18)
  • 1
    • 0032417031 scopus 로고    scopus 로고
    • Wegener's granulomatosis: Patient-reported effects of disease on health, function, and income
    • Hoffman GS, Drucker Y, Cotch MF, et al. Wegener's granulomatosis: patient-reported effects of disease on health, function, and income. Arthritis Rheum 1998;41:2257-62,
    • (1998) Arthritis Rheum , vol.41 , pp. 2257-2262
    • Hoffman, G.S.1    Drucker, Y.2    Cotch, M.F.3
  • 2
    • 0026505235 scopus 로고
    • Wegener's granulomatosis: An analysis of 158 patients
    • Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Int Med 1992;116:488-98.
    • (1992) Ann Int Med , vol.116 , pp. 488-498
    • Hoffman, G.S.1    Kerr, G.S.2    Leavitt, R.Y.3
  • 3
    • 0025183423 scopus 로고
    • The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis
    • Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
    • (1990) Arthritis Rheum , vol.33 , pp. 1101-1107
    • Leavitt, R.Y.1    Fauci, A.S.2    Bloch, D.A.3
  • 4
    • 0032186118 scopus 로고    scopus 로고
    • Antineutrophil cytoplasmic antibodies
    • Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Bull Rheum Dis 1998;47(6):5-8.
    • (1998) Bull Rheum Dis , vol.47 , Issue.6 , pp. 5-8
    • Hoffman, G.S.1    Specks, U.2
  • 5
    • 0031056295 scopus 로고    scopus 로고
    • Primary systemic vasculitis
    • Savage COS, Harper L, Adu D. Primary systemic vasculitis. Lancet 1997;349:553-8.
    • (1997) Lancet , vol.349 , pp. 553-558
    • Savage, C.O.S.1    Harper, L.2    Adu, D.3
  • 7
    • 0015764397 scopus 로고
    • Wegener's granulomatosis: Studies in eighteen patients and a review of the literature
    • Wolff AS, Fauci SM. Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine 1973;52:535-61.
    • (1973) Medicine , vol.52 , pp. 535-561
    • Wolff, A.S.1    Fauci, S.M.2
  • 8
    • 0020656868 scopus 로고
    • Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years
    • Fauci, AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Int Med 1983;98:76-85.
    • (1983) Ann Int Med , vol.98 , pp. 76-85
    • Fauci, A.S.1    Haynes, B.F.2    Katz, P.3    Wolff, S.M.4
  • 9
    • 0002737870 scopus 로고
    • Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis
    • Stegeman CA, Cohen Tervaert JW, Sluiter WJ, et al. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Int Med 1994;120:12-17.
    • (1994) Ann Int Med , vol.120 , pp. 12-17
    • Stegeman, C.A.1    Cohen Tervaert, J.W.2    Sluiter, W.J.3
  • 10
    • 0024426605 scopus 로고
    • Association between active Wegener's granulomatosis and anticytoplasmic antibodies
    • Cohen Tervaert JW, Fokko J, Fauci AS, et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989;149:2461-5.
    • (1989) Arch Intern Med , vol.149 , pp. 2461-2465
    • Cohen Tervaert, J.W.1    Fokko, J.2    Fauci, A.S.3
  • 11
    • 0027536455 scopus 로고
    • Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis
    • Kerr GS, Fleisher TA, Hallahan CW, et al. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1994;36:365-71.
    • (1994) Arthritis Rheum , vol.36 , pp. 365-371
    • Kerr, G.S.1    Fleisher, T.A.2    Hallahan, C.W.3
  • 12
    • 13344277271 scopus 로고    scopus 로고
    • Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener's granulomatosis
    • Talar-Williams C, Hijazi YM, Walther MM, et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener's granulomatosis. Ann Intern Med 1996;124:477-84.
    • (1996) Ann Intern Med , vol.124 , pp. 477-484
    • Talar-Williams, C.1    Hijazi, Y.M.2    Walther, M.M.3
  • 13
    • 15644362541 scopus 로고    scopus 로고
    • A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus glucocorticoids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis
    • Guillevin L, Cordier JF, Lhote F, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus glucocorticoids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997;40:2187-98.
    • (1997) Arthritis Rheum , vol.40 , pp. 2187-2198
    • Guillevin, L.1    Cordier, J.F.2    Lhote, F.3
  • 14
    • 0028969403 scopus 로고
    • An analysis of 42 Wegener's granulomatosis patients treated with methotrexate and prednisone
    • Sneller MC, Hoffman GS, Talar-Williams C, et al. An analysis of 42 Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum 1995;38:608-13.
    • (1995) Arthritis Rheum , vol.38 , pp. 608-613
    • Sneller, M.C.1    Hoffman, G.S.2    Talar-Williams, C.3
  • 15
    • 0030000725 scopus 로고    scopus 로고
    • Guidelines for monitoring drug therapy in rheumatoid arthritis
    • American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 1996;39:723-31.
    • (1996) Arthritis Rheum , vol.39 , pp. 723-731
  • 16
    • 0030028966 scopus 로고    scopus 로고
    • Response to trimethoprim/sulfamethoxazole in WG depends on the phase of the disease
    • Reinhold-Keller, DeGroot K, Rudert H, et al. Response to trimethoprim/sulfamethoxazole in WG depends on the phase of the disease. QJM 1996;89:15-23.
    • (1996) QJM , vol.89 , pp. 15-23
    • Reinhold-Keller1    DeGroot, K.2    Rudert, H.3
  • 17
    • 0030464106 scopus 로고    scopus 로고
    • Therapy for the maintenance of remission in 65 patients with generalized Wegener's granulomatosis: Methotrexate versus trimethoprim/sulfamethoxazole
    • DeGroot K, Reinhold-Keller E, Tatsis F, et al. Therapy for the maintenance of remission in 65 patients with generalized Wegener's granulomatosis: methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum 1996;39:2052-61.
    • (1996) Arthritis Rheum , vol.39 , pp. 2052-2061
    • DeGroot, K.1    Reinhold-Keller, E.2    Tatsis, F.3
  • 18
    • 0029946561 scopus 로고    scopus 로고
    • Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis
    • For the Dutch co-trimoxazole study group
    • Stegeman CA, Cohen Tervaert, de Jong PE, Kallenberg CGM. For the Dutch co-trimoxazole study group. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996;335:16-20.
    • (1996) N Engl J Med , vol.335 , pp. 16-20
    • Stegeman, C.A.1    Cohen Tervaert2    De Jong, P.E.3    Kallenberg, C.G.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.